Table 2 LVI Positivity amongst reviewers before and after Immunohistochemistry
From: Assessment of lymphovascular invasion in early stage endometrial carcinoma -a retrospective study
LVI | Reviewer 1 [n = 32(%)] | Reviewer 2 [n = 32(%)] | Reviewer 3 [n = 32(%)] | ||
|---|---|---|---|---|---|
Without IHC | With IHC | Without IHC | With IHC | ||
None | 30 (93.8 %) | 21 (65.6 %) | 21 (65.6 %) | 20(62.5 %) | 21 (65.6 %) |
Present | 2 (6.3 %) | 11 (34.4 %) | 11 (34.4 %) | 12 (37.5 %) | 11 (34.4 %) |
LVI Grade | Without IHC | With IHC | Without IHC | With IHC | |
None | 30 (93.8 %) | 21 (65.6 %) | 21 (65.6 %) | 20 (62.5 %) | 21 (65.6 %) |
Focal | 0 | 5 (15.6 %) | 3 (9.4 %) | 4 (12.5 %) | 3 (9.4 %) |
Substantial | 2 (6.3 %) | 6 (18.8 %) | 8 (25.0 %) | 8 (25.0) | 8 (25.0 %) |